VUNO will participate in Arab Health 2024, the Middle East’s largest medical device exhibition, in Dubai from Jan. 29 to Feb. 1.

At Arab Health 2024, VUNO will showcase its five key medical imaging and vital signs products. They are VUNO Med-Deep Brain, VUNO Med-Chest CT AI, VUNO Med-Chest X-ray, VUNO Med-Fundus AI, and VUNO Med-BoneAge, as well as the home ECG measurement device, Hativ P30.

In addition, the company plans to explore new business opportunities through meetings with buyers and company representatives from overseas and inform them of its overseas achievements, including VUNO Med-Deep Brain, which is about to enter the U.S. market, and VUNO Med-Chest CT AI sold in Japan.

"Arab Health 2024 is a large-scale event that attracts buyers and industry officials from all over the world beyond the Middle East, so it is a great opportunity to secure new partnerships," VUNO CEO Lee Yeha said. "We will actively promote the clinical validity and utilization cases of each product entering the healthcare market in various countries to accelerate our entry into overseas markets."

Arab Health is the largest medical device exhibition in the Middle East, held annually since 1976, marking its 49th event this year. It attracts more than 100,000 hospital officials and buyers every year and is known as the place to share the latest technology trends in the medical field and exchange business information. More than 3,400 companies from more than 180 countries are expected to participate this year.